Newsroom Bayer
WEBResults from the pivotal Phase III ARANOTE trial evaluating darolutamide plus androgen deprivation therapy (ADT) showed a statistically significant increase in radiological progression-free survival (rPFS) compared to placebo plus ADT in patients …. Read more.
Bayer CEO calls German group ‘badly broken’ as he holds off split
WEBMar 5, 2024 · Struggling German conglomerate Bayer is “badly broken” and currently unable to split up, chief executive Bill Anderson said on Tuesday.
Bayer aims to enhance performance and regain strategic flexibility …
WEBMar 5, 2024 · The division’s most recent product launches achieved significant gains, with growth rates of 93.6 percent (Fx & portfolio adj.) for the cancer drug Nubeqa™ and 160.6 percent (Fx & portfolio adj.) for Kerendia™, for the treatment of chronic kidney disease associated with type 2 diabetes.
Bayer shares soar after U.S. legal win against Roundup cancer claims
WEBAug 16, 2024 · Bayer shares rose as the company said it scored a legal victory in its suit over claims that exposure to its popular Roundup weed killer led to cancer.
Bayer aims to sustainably improve performance with new organization
WEBLeverkusen, January 17, 2024 – The Bayer Group is introducing a new operating model called “Dynamic Shared Ownership” (DSO) worldwide, which will reduce hierarchies, eliminate bureaucracy, streamline structures and accelerate decision-making processes. The aim of the new operating model is to make the company much more agile and ...
Bayer calls off break-up to tackle challenges for up to 3 years
WEBFRANKFURT, March 5 (Reuters) - Bayer (BAYGn.DE) will hold off on plans to break apart the group for up to three years so that the new CEO can focus on problems including debt and litigation ...
Exclusive: Bayer investor Artisan calls for breakup of company
WEBAug 25, 2023 · Bayer needs to make major changes, including "de-merging" two of its three business arms, investor Artisan Partners told Reuters on Friday, adding to a chorus of demand for change from other ...
Bayer's first-quarter adjusted profit falls less than expected
WEBMay 14, 2024 · Bayer beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts.
Bayer Fights for Survival as Roundup Lawsuits Burn Cash - Bloomberg.com
WEBMay 23, 2024 · Bayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its Roundup weedkiller is an “existential” threat to the company and farmers, ratcheting up the stakes as it ...
Bayer Reports Encouraging NSCLC Drug Data, Gets Approval for …
WEBSep 10, 2024 · Bayer BAYRY announced positive results from the expansion part of the ongoing early to mid-stage study on pipeline candidate BAY 2927088. BAY 2927088 is an oral, reversible tyrosine kinase ...